Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension

The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-&agr; (TNF-&agr;), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47±1 years of age; mean±SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-&agr;, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate–corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-&agr; (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension.

[1]  C. Reid,et al.  Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly. , 2001, American journal of hypertension.

[2]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[3]  T. Saruta,et al.  Long-term effects of statins on arterial pressure and stiffness of hypertensives , 2005, Journal of Human Hypertension.

[4]  K. Fischer,et al.  High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons , 2004, Journal of hypertension.

[5]  M E Safar,et al.  Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. , 1999, Journal of hypertension.

[6]  H. Koide,et al.  Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. , 2004, Metabolism: clinical and experimental.

[7]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[8]  Yasmin,et al.  C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[9]  D. Webb,et al.  Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. , 2002, British journal of clinical pharmacology.

[10]  Aroon D. Hingorani,et al.  Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans , 1999, Circulation.

[11]  Azra Mahmud,et al.  Arterial stiffness and the renin-angiotensin-aldosterone system. , 2004, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[12]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Yasmin,et al.  Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[14]  M. Hori,et al.  Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. , 2003, Atherosclerosis.

[15]  D. Webb,et al.  The influence of heart rate on augmentation index and central arterial pressure in humans , 2000, The Journal of physiology.

[16]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[17]  M. Di Napoli,et al.  Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke , 2003, Stroke.

[18]  S. Fichtlscherer,et al.  Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease , 2000, Circulation.

[19]  Azra Mahmud,et al.  Review: Arterial stiffness and the renin-angiotensin-aldosterone system , 2004 .

[20]  M E Safar,et al.  Arterial Wave Reflections and Survival in End-Stage Renal Failure , 2001, Hypertension.

[21]  Yasmin,et al.  Determinants of arterial stiffness in offspring of families with essential hypertension. , 2004, American journal of hypertension.

[22]  P. Ridker,et al.  High-sensitivity C-reactive protein: clinical importance. , 2004, Current problems in cardiology.

[23]  Azra Mahmud,et al.  Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. , 2002, American journal of hypertension.

[24]  A. Hofman,et al.  C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. , 2004, Atherosclerosis.

[25]  Thomas Weber,et al.  Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease , 2004, Circulation.

[26]  A. Aljada,et al.  Evidence for a potent antiinflammatory effect of rosiglitazone. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[28]  L. Bautista,et al.  Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension , 2005, Journal of Human Hypertension.

[29]  Nico Westerhof,et al.  Increased Central Artery Stiffness in Impaired Glucose Metabolism and Type 2 Diabetes: The Hoorn Study , 2004, Hypertension.

[30]  M. Hori,et al.  Relationship Between C-Reactive Protein and Progression of Early Carotid Atherosclerosis in Hypertensive Subjects , 2004, Stroke.

[31]  Yasmin,et al.  Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. , 2004, Arthritis and rheumatism.

[32]  S. Julius,et al.  Elevated Heart Rate: A Major Risk Factor for Cardiovascular Disease , 2004, Clinical and experimental hypertension.

[33]  P. Ridker,et al.  Blood Pressure and Inflammation in Apparently Healthy Men , 2001, Hypertension.

[34]  J. Ruidavets,et al.  Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness , 2004, Journal of hypertension.